Article Details

Acceleron Pharma Inc. (NASDAQ:XLRN) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-01-25 11:34:37

Tags for this article:

Click the tags to see associated articles and topics

Acceleron Pharma Inc. (NASDAQ:XLRN) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 4,641,005 shares of the biopharmaceutical company's stock worth $522,254,000 after acquiring an additional 204,593 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo